Search

everythinglearnresearchcommunity

for

Search:↓

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Women may need different blood pressure guidelines than men for heart disease prevention.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Male and female mice handle stress differently.

Male and female mice handle stress differently.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Finasteride worsens alcohol withdrawal in female mice but eases it in male mice.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Urticaria patients have different skinfold thickness patterns compared to healthy individuals, with some variations between men and women.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Dermatologists are crucial in providing personalized care for patients with sex development differences.